transferrin has been researched along with Minimal Disease, Residual in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, BC; Hong, CM; Jeong, JH; Jeong, SY; Jung, JH; Kim, CY; Lee, CH; Lee, J; Lee, SW; Son, SH | 1 |
| Balaguer, MG; Bartenstein, P; Basso, M; Calabuig, EC; Haug, A; Magner, J; Maini, CL; Mazzarotto, R; Monari, F; Muros de Fuentes, MA; Petrich, T; Rodrigues, FJ; Sciuto, R; Vallejo Casas, JA; Vaňó, RS; Vianello, F | 1 |
| Campbell, J; Fink-Bennett, D; Wu, D | 1 |
| Bailey, M; Cherk, MH; Francis, P; Kalff, V; Topliss, DJ | 1 |
| Bagnasco, M; Banti, E; Bombardieri, E; Dottorini, ME; Fugazzola, L; Maffioli, L; Perotti, G; Rubello, D; Seregni, E; Testori, O | 1 |
| Molinaro, E; Pieruzzi, L; Viola, D | 1 |
2 review(s) available for transferrin and Minimal Disease, Residual
| Article | Year |
|---|---|
[Radiometabolic therapy for metastatic thyroid carcinoma: overview of the literature and rational bases for the use of recombinant human TSH].
Topics: Carcinoma; Clinical Trials, Phase II as Topic; Humans; Iodine Radioisotopes; Italy; Neoplasm Recurrence, Local; Neoplasm, Residual; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa | 2012 |
Radioiodine post-surgical remnant ablation in patients with differentiated thyroid cancer: news from the last 10 years.
Topics: Carcinoma, Papillary, Follicular; Catheter Ablation; Cell Differentiation; Combined Modality Therapy; Humans; Iodine Radioisotopes; Neoplasm, Residual; Thyroid Neoplasms; Thyrotropin Alfa; Time Factors | 2012 |
4 other study(ies) available for transferrin and Minimal Disease, Residual
| Article | Year |
|---|---|
I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer: comparison between recombinant human TSH administration and thyroid hormone withdrawal.
Topics: Chemoradiotherapy; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome; Whole Body Imaging | 2017 |
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm, Residual; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome; Young Adult | 2014 |
Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation.
Topics: Carcinoma; Carcinoma, Papillary; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Postoperative Complications; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Treatment Outcome | 2014 |
Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
Topics: Autoantibodies; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Neoplasm, Residual; Outcome Assessment, Health Care; Retrospective Studies; Risk Assessment; Risk Factors; Thyroglobulin; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa | 2012 |